• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

药剂师干预对缺血性脑卒中门诊患者可改变危险因素的控制:一项均衡分配分层随机研究。

Control of modifiable risk factors in ischemic stroke outpatients by pharmacist intervention: an equal allocation stratified randomized study.

作者信息

Chiu Chun-Chi, Wu Shin-Sheng, Lee Ping-Yi, Huang Yu-Ching, Tan Teng-Yeow, Chang Ku-Chou

机构信息

Department of Pharmacy, Chang Gung Memorial Hospital, Kaohsiung, Taiwan.

出版信息

J Clin Pharm Ther. 2008 Oct;33(5):529-35. doi: 10.1111/j.1365-2710.2008.00940.x.

DOI:10.1111/j.1365-2710.2008.00940.x
PMID:18834368
Abstract

OBJECTIVE

To evaluate the adequacy of management of modifiable risk factors (MRF) in a group of ischemic stroke outpatients and the value of pharmacist intervention in a randomized controlled study in a tertiary referral hospital.

METHODS

160 ischemic stroke outpatients from the same catchment area and with the same financial arrangements for healthcare, went through a 6-month equal allocation stratified randomized study. Routine practice was not altered except for a monthly 1-hour pharmacist-intervention education programme. We evaluated the differences in blood pressure (BP), blood glucose and lipid profiles before and after study. The proportion of patients with adequate management of MRF was studied.

RESULTS

There were no differences in the demographic characteristics, MRF and medications prescribed throughout the study. Before the study, the proportions of adequate control of BP in the control and intervention groups were 43% vs. 40% (P = 0.64), lipid 27% vs. 13% (P = 0.09) and glucose 36% vs. 21% (P = 0.15) . At the end of the study, the corresponding proportions were for BP 43% vs. 83% (P = 0.00), lipid 27% vs. 40% (P = 0.16) and glucose 46% vs. 35% (P = 0.40).

CONCLUSION

Pharmacist intervention was associated with improved BP control but not with the other MRF. Earlier initiation and longer duration of intervention may improve the outcome further, and whether targeting of high-risk subjects may be particularly rewarding is worthy of investigation.

摘要

目的

在一所三级转诊医院开展的一项随机对照研究中,评估一组缺血性脑卒中门诊患者中可改变风险因素(MRF)的管理是否充分以及药师干预的价值。

方法

160名来自同一服务区域且医疗保健费用安排相同的缺血性脑卒中门诊患者,接受了为期6个月的等比分层随机研究。除了每月1小时的药师干预教育项目外,常规治疗未作改变。我们评估了研究前后血压(BP)、血糖和血脂水平的差异。研究了MRF管理充分的患者比例。

结果

在整个研究过程中,两组患者的人口统计学特征、MRF和所开药物均无差异。研究前,对照组和干预组血压控制充分的比例分别为43%和40%(P = 0.64),血脂分别为27%和13%(P = 0.09),血糖分别为36%和21%(P = 0.15)。研究结束时,相应的比例血压为43%和83%(P = 0.00),血脂为27%和40%(P = 0.16),血糖为46%和35%(P = 0.40)。

结论

药师干预与血压控制改善相关,但与其他MRF无关。更早开始并延长干预持续时间可能会进一步改善结果,针对高危患者是否可能特别有效值得研究。

相似文献

1
Control of modifiable risk factors in ischemic stroke outpatients by pharmacist intervention: an equal allocation stratified randomized study.药剂师干预对缺血性脑卒中门诊患者可改变危险因素的控制:一项均衡分配分层随机研究。
J Clin Pharm Ther. 2008 Oct;33(5):529-35. doi: 10.1111/j.1365-2710.2008.00940.x.
2
Pharmacist intervention program for control of hypertension.控制高血压的药剂师干预计划。
Ann Pharmacother. 2003 Sep;37(9):1186-93. doi: 10.1345/aph.1C267.
3
A randomized trial of the effect of community pharmacist and nurse care on improving blood pressure management in patients with diabetes mellitus: study of cardiovascular risk intervention by pharmacists-hypertension (SCRIP-HTN).一项关于社区药剂师和护士护理对改善糖尿病患者血压管理效果的随机试验:药剂师-高血压心血管风险干预研究(SCRIP-HTN)。
Arch Intern Med. 2008 Nov 24;168(21):2355-61. doi: 10.1001/archinte.168.21.2355.
4
Pharmacist monitoring of QTc interval-prolonging medications in critically ill medical patients: a pilot study.药剂师对重症内科患者中可延长QTc间期药物的监测:一项试点研究。
Ann Pharmacother. 2008 Apr;42(4):475-82. doi: 10.1345/aph.1K458. Epub 2008 Mar 4.
5
A pharmacist care program: positive impact on cardiac risk in patients with type 2 diabetes.药师护理方案:对 2 型糖尿病患者心脏风险的积极影响。
J Cardiovasc Pharmacol Ther. 2012 Mar;17(1):57-64. doi: 10.1177/1074248410396216. Epub 2011 Feb 18.
6
Clinical impact of a pharmacist-physician co-managed programme on hyperlipidaemia management in Hong Kong.
J Clin Pharm Ther. 2009 Aug;34(4):407-14. doi: 10.1111/j.1365-2710.2009.01024.x.
7
[Improving blood pressure control with physician/pharmacist collaboration].通过医生/药剂师合作改善血压控制
Vnitr Lek. 2009 Apr;55(4):389-94.
8
Discharge medications among ischemic stroke survivors.缺血性中风幸存者的出院用药情况。
J Stroke Cerebrovasc Dis. 2009 Mar-Apr;18(2):97-102. doi: 10.1016/j.jstrokecerebrovasdis.2008.08.005.
9
Randomized trial to improve laboratory safety monitoring of ongoing drug therapy in ambulatory patients.改善门诊患者正在进行的药物治疗实验室安全监测的随机试验。
Pharmacotherapy. 2006 May;26(5):619-26. doi: 10.1592/phco.26.5.619.
10
Lipid-lowering drugs in ischemic stroke prevention and their influence on acute stroke outcome.用于缺血性卒中预防的降脂药物及其对急性卒中结局的影响。
Cerebrovasc Dis. 2009;27 Suppl 1:126-33. doi: 10.1159/000200450. Epub 2009 Apr 3.

引用本文的文献

1
The effect of clinical pharmacist-led pharmaceutical care services on medication adherence, clinical outcomes and quality of life in patients with stroke: a randomised controlled trial.临床药师主导的药学服务对脑卒中患者用药依从性、临床结局及生活质量的影响:一项随机对照试验
Int J Clin Pharm. 2025 Feb;47(1):99-106. doi: 10.1007/s11096-024-01811-0. Epub 2024 Oct 12.
2
Role of Health Care Professionals in the Success of Blood Pressure Control Interventions in Patients With Hypertension: A Meta-Analysis.卫生保健专业人员在高血压患者血压控制干预措施成功中的作用:一项荟萃分析。
Circ Cardiovasc Qual Outcomes. 2024 Aug;17(8):e010396. doi: 10.1161/CIRCOUTCOMES.123.010396. Epub 2024 Jul 19.
3
The effect of the multimodal intervention on blood pressure in patients with first ischemic stroke: A randomized controlled trial.
多模式干预对首次缺血性卒中患者血压的影响:一项随机对照试验。
Belitung Nurs J. 2023 Feb 12;9(1):34-42. doi: 10.33546/bnj.2432. eCollection 2023.
4
The Role of Pharmacists in Providing Pharmaceutical Care in Primary and Secondary Prevention of Stroke: A Systematic Review and Meta-Analysis.药剂师在中风一级和二级预防中提供药学服务的作用:一项系统评价和荟萃分析
Healthcare (Basel). 2022 Nov 18;10(11):2315. doi: 10.3390/healthcare10112315.
5
Information provision for stroke survivors and their carers.为脑卒中幸存者及其照护者提供信息。
Cochrane Database Syst Rev. 2021 Nov 23;11(11):CD001919. doi: 10.1002/14651858.CD001919.pub4.
6
Quality of Stroke Patient Information Applied in Randomized Controlled Trials-Literature Review.随机对照试验中应用的中风患者信息质量——文献综述
Front Neurol. 2020 Dec 7;11:526515. doi: 10.3389/fneur.2020.526515. eCollection 2020.
7
Triglyceride Glucose Index and Prognosis of Patients With Ischemic Stroke.甘油三酯葡萄糖指数与缺血性脑卒中患者的预后
Front Neurol. 2020 Jun 10;11:456. doi: 10.3389/fneur.2020.00456. eCollection 2020.
8
Blood pressure after follow-up in a stroke prevention clinic.随访后的血压:预防中风诊所。
Brain Behav. 2020 Aug;10(8):e01667. doi: 10.1002/brb3.1667. Epub 2020 Jun 12.
9
A pilot study to assess the practicality, acceptability and feasibility of a randomised controlled trial to evaluate the impact of a pharmacist complex intervention on patients with stroke in their own homes.一项初步研究,旨在评估一项随机对照试验的实用性、可接受性和可行性,该试验旨在评估药剂师综合干预措施对居家中风患者的影响。
Eur J Hosp Pharm. 2017 Mar;24(2):101-106. doi: 10.1136/ejhpharm-2016-000918. Epub 2016 Aug 8.
10
Interventions for improving modifiable risk factor control in the secondary prevention of stroke.改善卒中二级预防中可改变危险因素控制的干预措施。
Cochrane Database Syst Rev. 2018 May 7;5(5):CD009103. doi: 10.1002/14651858.CD009103.pub3.